Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWP
2976
New Pacific Metals
NEWP
$353M
| $386K | ﹤0.01% |
+287,993
| New | +$386K |
|
2977
Electro-Sensors
ELSE
$16.2M
| $385K | ﹤0.01% |
92,300
-2,500
| -3% | -$10.4K |
|
|
OBE
2978
Obsidian Energy
OBE
$417M
| $383K | ﹤0.01% |
46,400
+8,100
| +21% | +$66.9K |
|
2979
CRISPR Therapeutics
CRSP
$5.08B
| $382K | ﹤0.01% |
+5,599
| New | +$382K |
|
2980
YieldMax TSLA Option Income Strategy ETF
TSLY
$1.19B
| $381K | ﹤0.01% |
23,656
-11,744
| -33% | -$189K |
|
|
ZFOX
2981
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $381K | ﹤0.01% |
340,200
-24,405
| -7% | -$27.3K |
|
|
CRESY
2982
Cresud
CRESY
$545M
| $378K | ﹤0.01% |
42,296
+8,460
| +25% | +$75.6K |
|
2983
Evolus
EOLS
$475M
| $378K | ﹤0.01% |
27,000
-238,700
| -90% | -$3.34M |
|
2984
Guild Holdings
GHLD
$1.24B
| $378K | ﹤0.01% |
25,600
+700
| +3% | +$10.3K |
|
2985
Avita Medical
RCEL
$113M
| $378K | ﹤0.01% |
23,600
-13,200
| -36% | -$211K |
|
2986
Dolby
DLB
$6.8B
| $377K | ﹤0.01% |
4,500
-34,700
| -89% | -$2.91M |
|
2987
Vince Holding
VNCE
$40.3M
| $377K | ﹤0.01% |
116,050
-1,600
| -1% | -$5.2K |
|
2988
Compass Diversified
CODI
$528M
| $375K | ﹤0.01% |
15,600
-25,700
| -62% | -$618K |
|
2989
Hawthorn Bancshares
HWBK
$219M
| $375K | ﹤0.01% |
+18,343
| New | +$375K |
|
2990
Dare Bioscience
DARE
$28.7M
| $374K | ﹤0.01% |
63,575
+3,625
| +6% | +$21.3K |
|
2991
First Savings Financial Group
FSFG
$190M
| $374K | ﹤0.01% |
22,300
+600
| +3% | +$10.1K |
|
2992
iShares S&P 500 Value ETF
IVE
$41.3B
| $374K | ﹤0.01% |
2,000
-12,978
| -87% | -$2.43M |
|
2993
TScan Therapeutics
TCRX
$105M
| $373K | ﹤0.01% |
47,000
+25,300
| +117% | +$201K |
|
2994
NeueHealth
NEUE
$60.8M
| $373K | ﹤0.01% |
57,363
-800
| -1% | -$5.2K |
|
2995
Nautilus Biotechnolgy
NAUT
$89.2M
| $370K | ﹤0.01% |
126,000
+9,300
| +8% | +$27.3K |
|
2996
iShares Select U.S. REIT ETF
ICF
$1.94B
| $369K | ﹤0.01% |
+6,400
| New | +$369K |
|
2997
Healthcare Services Group
HCSG
$1.2B
| $369K | ﹤0.01% |
29,564
-22,600
| -43% | -$282K |
|
2998
Investar Holding Corp
ISTR
$225M
| $366K | ﹤0.01% |
22,375
-8,500
| -28% | -$139K |
|
2999
Toro Corp
TORO
$54.4M
| $366K | ﹤0.01% |
68,200
-9,193
| -12% | -$49.3K |
|
3000
Bitdeer Technologies
BTDR
$3.02B
| $365K | ﹤0.01% |
+52,026
| New | +$365K |
|